oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes Medications like Tirzepatide are not just for and weight loss! Major clinical trials like PIONEER 6 and SUSTAIN 6 have shown that Semaglutide also significantly reduces the risk of oral semaglutide and cardiovascular outcomes

Check Out Our 5 Star Reviews Additional Services You May Need Primary Care Walk-In Clinic Medical-Weight Loss Flu Hypertension Asthma PFTs Telemedicine Broken Bones Urinalysis Bronchitis Ear Infection Hypothyroidism Chronic Care Arthritis Diabetes Heart Disease High Cholesterol Thyroid Disease Exercise Guidance Metabolic Monitoring Nutrition Counseling Semaglutide Tirzepatide Annual Physicals Lifestyle Coaching Medication Management Preventative Screening Cold & Flu Treatment Fractures Illnesses Treatment

Key clinical insight: The weight loss and metabolic improvements observed in retatrutide trials occurred without standardized carbohydrate protocols, which supports the hypothesis that this triple agonist does not require high carbohydrate availability to exert its core effects

Luo L, Nguyen DD, Lai

The main interest is around skin texture, collagen and elastin activity, connective tissue, hair and follicle research, and visible ageing biology

Although the research is promising, it is still pretty limited and focused more on psoriasis than psoriatic arthritis